Is Accendra Health, Inc. (ACH) a Buy, Sell, or Hold?
NYSE : ACH
Accendra Health, Inc.
$1.4 USD
-$1.4 (-50.0%)
- Volume
- 8.06M
- Average Volume
- 760.88K
- Market Capitalization
- $107.22M
- P/E Ratio
- -0.36
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $5.85
- Year Low
- $1.24
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.41
Company Overview
NYSE
Edward A. Pesicka
Medical - Distribution
Healthcare
ACH
6500
US
USD
Liquidity Metrics
-3.23
0.41
0.30
0.01
0.00
Sales & Valuation
$2.76B
0.04
-0.19
-0.63
-2.24
Profitability
-$14.31
-$1.1B
-11.41%
-4.36%
63.40%
-14.34%
P/E Metrics
-0.36
0.00
0.00
Analyst Price Target & Rating
$3.00
$4.50
$1.50
2/5
15 Analysts
-53.33%
Financial Health Scores
0.24
4/9
-$614.6M
$2.42B
$2.88B
$2.52M
Key Metrics (TTM)
$2.05B
0.75
8.68
0.49
264.54%
9.77%
-503.88%
-92.34%
-63 days
Company Executives
| Name | Title |
|---|---|
| Edward A. Pesicka | President, Chief Executive Officer & Director |
| Nicholas Piecora | Senior VP & Chief Information Officer |
| Agnes Ansay | VP & Chief Procurement Officer |
| Heath H. Galloway | Executive Vice President, General Counsel & Corporate Secretary |
| Colin Bain | Chief Products Officer |
| Jonathan A. Leon | Executive Vice President, Chief Financial Officer & Corporate Treasurer |
| Trudi Allcott | Director of Media Relations |
| Will Parrish | Vice President of Strategy of Corporate Development, & Investor Relations |
| Dirk Benson | Chief Commercial Officer |
| Perry A. Bernocchi | Executive VP & COO |
Poll Results
No votes yet today — be the first to share your view!
About Accendra Health, Inc. (NYSE:ACH) Stock
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor p ... artners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript
2026-08-10 13:08:28
Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript
2026-08-10 06:50:00
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) announced today that its Board of Directors adopted a Section 382 Rights Agreement (the “Tax Asset Preservation Plan”) designed to protect long-term shareholder value by facilitating the Company's ability to preserve its net operating loss carryforwards (“NOLs”) and certain other tax attributes. A company generally experiences an ownership change if the percentage of the value of its stock owned by certain “5-percen.
Accendra Health Reports Second Quarter 2026 Financial Results
2026-08-10 06:45:00
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the second quarter ended June 30, 2026. Unless otherwise noted, the results herein reflect the Company's continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. “Throughout the second quarter, we moved farther along toward the complete separation from Owens & Minor while also putting a large commercial payor exi.
2026-08-10 06:30:00
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that President and Chief Executive Officer Edward A. Pesicka has informed the Board of Directors of his plan to retire by the end of 2026, after more than seven years with the Company. Mr. Pesicka will also retire from the Company's Board of Directors before the end of the year. The Board of Directors maintains a long-standing, robust succession planning process established to address officer success.
2026-07-31 08:30:00
BOZEMAN, Mont.--(BUSINESS WIRE)--PSQ Holdings, Inc. (NYSE: PSQH) today announced that Guidefitter, the outdoor tech platform powering the industry's most comprehensive verified pro network, has selected Credova and PSQ Payments to power ACH payments across its marketplace checkout and the Guidefitter Wallet, the platform's digital wallet for its members. The transition comes just days after Guidefitter's existing ACH provider elected to stop processing transactions and confirms PSQ Payments' ab.
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
2026-07-27 10:00:00
Accendra Health, Inc. (NYSE: ACH) (the âCompanyâ) plans to release financial results for the second quarter of 2026 on Monday, August 10, 2026, before tradi
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
2026-07-27 09:15:00
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the second quarter of 2026 on Monday, August 10, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:00 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058.
Is the Options Market Predicting a Spike in Accendra Health Stock?
2026-07-02 10:06:30
Investors need to pay close attention to ACH stock based on the movements in the options market lately.
Frequently Asked Questions
-
What is the current Accendra Health, Inc. (ACH) stock price?
-
Accendra Health, Inc.(NYSE:ACH) stock price is $1.4 in the last trading session. During the trading session, ACH stock reached the peak price of $5.85 while $1.24 was the lowest point it dropped to. The percentage change in ACH stock occurred in the recent session was --50.0% while the dollar amount for the price change in ACH stock was -$1.4.
-
ACH's industry and sector of operation?
-
The NYSE listed ACH is part of Medical - Distribution industry that operates in the broader Healthcare sector.
-
Who are the executives of ACH?
-
Edward A. Pesicka | President, Chief Executive Officer & Director
Nicholas Piecora | Senior VP & Chief Information Officer
Agnes Ansay | VP & Chief Procurement Officer
Heath H. Galloway | Executive Vice President, General Counsel & Corporate Secretary
Colin Bain | Chief Products Officer -
How many employees does ACH have?
-
Number of ACH employees currently stands at 6500. ACH operates from 4435 Waterfront Drive, Glen Allen, VA 23060, US.
-
Link for ACH official website?
-
Official Website of ACH is: https://www.accendrahealth.com
-
How do I contact ACH?
-
ACH could be contacted at phone #804 723 7000 and can also be accessed through its website. ACH operates from 4435 Waterfront Drive, Glen Allen, VA 23060, US.
-
How many shares of ACH are traded daily?
-
The average number of ACH shares traded daily for last 3 months was 760.88K.
-
What is the market cap of ACH currently?
-
The market value of ACH currently stands at $107.22M with its latest stock price at $1.4